Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Johannes M. Werzowa
Observed names:
J Werzowa,
J. Werzowa,
Johannes Werzowa,
Werzowa, J.
Institution:
Hanusch Hospital
Observed institutions:
University of Vienna,
AIT Austrian Institute of Technology GmbH,
Research Institute of Molecular Pathology,
Hospital Universitario de Canarias,
Hanusch Hospital,
Arbor Research Collaborative for Health,
Ludwig Boltzmann Institute of Osteology,
Medical University of Vienna
show all 8
ORCID:
0000-0003-2507-1377
Observed ORCID:
0000-0003-2507-1377
OpenAlex ID:
A5090118471
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
2017
·
Marlies Antlanger
, Stefan Aschauer
, et al.
·
Kidney & Blood Pressure Research
·
2,834
PDF
The STIR-domain superfamily in signal transduction, development and immunity
2003
·
Maria Novatchkova
, Andreas Leibbrandt
, et al.
·
Trends in Biochemical Sciences
·
266
Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation
2012
·
Manfred Hecking
, Michael Haidinger
, et al.
·
Journal of the American Society of Nephrology
·
226
Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation
2007
·
Wolfgang Sieghart
, Thorsten Fuereder
, et al.
·
Transplantation
·
155
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
2018
·
Elisabeth Schwaiger
, Lukas Burghart
, et al.
·
American Journal of Transplantation
·
138
Glucose Metabolism After Renal Transplantation
2013
·
Manfred Hecking
, Alexander Kainz
, et al.
·
Diabetes Care
·
125
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
2013
·
M. Hecking
, J. Werzowa
, et al.
·
Nephrology Dialysis Transplantation
·
122
Efficacy and Safety of Vildagliptin in New-Onset Diabetes After Kidney Transplantation—A Randomized, Double-Blind, Placebo-Controlled Trial
2013
·
M. Haidinger
, J. Werzowa
, et al.
·
American Journal of Transplantation
·
111
PDF
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status
2013
·
Marlies Antlanger
, Manfred Hecking
, et al.
·
BMC Nephrology
·
103
PDF
CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages
2012
·
M. Poglitsch
, T. Weichhart
, et al.
·
American Journal of Transplantation
·
89
Vildagliptin and Pioglitazone in Patients With Impaired Glucose Tolerance After Kidney Transplantation: A Randomized, Placebo-Controlled Clinical Trial
2013
·
Johannes Werzowa
, Manfred Hecking
, et al.
·
Transplantation
·
87
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo
2008
·
Daniel Cejka
, Matthias Preusser
, et al.
·
Cancer Biology & Therapy
·
70
PDF
Dual inhibition of EGFR and mTOR pathways in small cell lung cancer
2010
·
K Schmid
, Z Bago-Horvath
, et al.
·
British Journal of Cancer
·
65
PDF
Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo
2010
·
Johannes Werzowa
, Stefan Koehrer
, et al.
·
Journal of Investigative Dermatology
·
52
PDF
Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial
2021
·
Elisabeth Schwaiger
, Simon Krenn
, et al.
·
Journal of the American Society of Nephrology
·
42
Molecular regulation of the renin–angiotensin system in haemodialysis patients
2014
·
Johannes J. Kovarik
, Marlies Antlanger
, et al.
·
Nephrology Dialysis Transplantation
·
41
Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties
2014
·
Chantal Kopecky
, Michael Haidinger
, et al.
·
Journal of the American Society of Nephrology
·
41
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo
2009
·
D Cejka
, C Kuntner
, et al.
·
British Journal of Cancer
·
39
PDF
Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002
2008
·
J. Werzowa
, D. Cejka
, et al.
·
British Journal of Dermatology
·
37
Comparison of a Treatment Strategy Combining CCI-779 Plus DTIC Versus DTIC Monotreatment in Human Melanoma in SCID Mice
2007
·
Christiane Thallinger
, Johannes Werzowa
, et al.
·
Journal of Investigative Dermatology
·
35
Gastric Cancer Growth Control by BEZ235 In Vivo Does Not Correlate with PI3K/mTOR Target Inhibition but with [18F]FLT Uptake
2011
·
Thorsten Fuereder
, Thomas Wanek
, et al.
·
Clinical Cancer Research
·
33
mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
2008
·
Daniel Cejka
, Matthias Preusser
, et al.
·
PubMed
·
30
Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD).
2019
·
Barbara M Misof
, Stéphane Blouin
, et al.
·
PubMed Central
·
27
PDF
Late onset Pneumocystis pneumonia in renal transplantation after long‐term immunosuppression with belatacept
2009
·
M. Haidinger
, M. Hecking
, et al.
·
Transplant Infectious Disease
·
25
Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients
2016
·
Johannes J. Kovarik
, Chantal Kopecky
, et al.
·
The Journal of Heart and Lung Transplantation
·
20
Show more works
View as search
Works count:
84
Citation count:
5,158
H-index:
24
I10-index:
43
Year
Topic
Type
